Theravance Biopharma, Inc. (TBPH)
20.69
+0.32
(+1.57%)
USD |
NASDAQ |
Jan 22, 13:49
Theravance Biopharma Price: 20.69 for Jan. 22, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Corcept Therapeutics, Inc. | 41.46 |
| Perspective Therapeutics, Inc. | 2.70 |
| Skye Bioscience, Inc. | 1.05 |
| Kyntra Bio, Inc. | 8.95 |
| Myomo, Inc. | 0.9611 |
Price Related Metrics
| PE Ratio | 36.78 |
| PS Ratio | 12.98 |
| Price to Book Value | 4.506 |
| Price to Free Cash Flow | 4.284 |
| Earnings Yield | 2.72% |
| Market Cap | 1.048B |
| Normalized PE Ratio | 36.78 |